Source: Virtual Congress 2021 – Interstitial lung disease around the world



Rating:

Share or cite this content

Citations should be made in the following way:
T. Prior (Aarhus, Denmark), C. Hyldgaard (Silkeborg, Denmark), S. Torrisi (Heidelberg, Germany), S. Kronborg-White (Aarhus, Denmark), C. Ganter (Heidelberg, Germany), M. Kreuter (Heidelberg, Germany), E. Bendstrup (Aarhus, Denmark). Clusters of comorbidities in unclassifiable interstitial lung disease. 3744

Member's Comments

No comment yet.

Related content which might interest you: Comorbidities in unclassifiable interstitial lung disease Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 Clinical characteristics of patients with unclassifiable interstitial lung disease Source: International Congress 2015 – New insights into IIPs Year: 2015 Prevalence and prognosis of unclassifiable interstitial lung disease Source: Eur Respir J 2013; 42: 750-757 Year: 2013 Prevalence and prognosis of unclassifiable interstitial lung disease Source: Eur Respir J 2014; 43: 1529-1530 Year: 2014 Comorbidities in interstitial lung diseases Source: Eur Respir Rev 2017; 26: 160027 Year: 2017 Unclassified or unclassifiable interstitial lung disease: confusing or helpful disease category? Source: Eur Respir J 2013; 42: 576-579 Year: 2013 Clusters of comorbidities in idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis Year: 2020 Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Clinical characteristics of 30 patients with interstitial pneumonia associated with anti-aminoacyl-tRNA-synthetase antibodies Source: International Congress 2016 – Connective tissue disorders Year: 2016 Co-morbidities and cause of death in patients with rheumatoid arthritis associated interstitial lung disease Source: International Congress 2015 – Connective tissue disorders Year: 2015 Study of factors affecting mortality in ILD cases over 2 years Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Clinical characteristics of anti-Jo-1-positive interstitial lung disease Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new? Year: 2019 Emphysema frequency in the cases who have interstitial lung disease diagnosis Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease Year: 2008 Variation in mortality from interstitial lung disease by diagnosis Source: International Congress 2015 – IIPs: orphan Year: 2015 The analysis of prognostic factors in patients with interstitial lung diseases Source: International Congress 2015 – New insights into IIPs Year: 2015 Prognostic relevance of histologic features in nonspecific interstitial pneumonia (NSIP) Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Associations between comorbidities and survival in patients with interstitial lung diseases Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases Year: 2021 Clubbing in patients with fibrotic interstitial lung diseases Source: International Congress 2017 – ILDs: clinical problems Year: 2017 Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Comorbidities in patients with the combined pulmonary fibrosis and emphysema syndrome (CPFE) Source: International Congress 2015 – Interstitial lung diseases II Year: 2015